Moonlake Immunotherapeutics
MLTX
Revenue
0.00
0.000.00%
-Assets
460.10M
▼-51.17M▼-10.01%
3 Months ChangeLiabilities
102.15M
▲3.47M▲3.52%
3 Months ChangeFree Cash Flow
-38.18M
▼-23.02M▼-151.81%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-11
Form 8-K
ID: 0001213900-24-077513
2024-08-07
Form 10-Q
ID: 0001821586-24-000025
2024-08-07
Form 8-K
ID: 0001821586-24-000024
2024-06-10
Form 8-K
ID: 0001213900-24-051263
2024-06-06
Form 8-K
ID: 0001213900-24-050194
2024-05-07
Form 10-Q
ID: 0001821586-24-000020
2024-05-07
Form 8-K
ID: 0001821586-24-000019
2024-03-11
Form 8-K
ID: 0001213900-24-021233
2024-02-29
Form 8-K
ID: 0001821586-24-000007
2024-02-26
Form 8-K
ID: 0001213900-24-016737